- An essential resource
- for general reference and competitive, technological, market and regulatory intelligence.
The reviews agree!
- "The most useful and cost-effective resource with the information you need to understand biopharmaceutical products and the industry."
- Emphasis on biotechnology and commercial aspects - composition, activity, nomenclature, companies involved and relationships,
manufacturing processes, patents/technology transfer, regulatory history/status, approved indications, prices, market size/share, controversial aspects, etc.
- Over 600 product monographs - includes all:
- recombinant and other proteins
- antibodies - monoclonal, radioimmune conjugates
- vaccines, including biodefense vaccines
- enzymes and toxins
- blood products - human and animal-derived
- cultured cell and tissue products
- and other products, e.g., vaccine adjuvants, antisense drugs, borderline drugs/biopharmaceuticals
- In-depth monographs - 593 over 2,000 characters in length; 469 over 5,000; 316 over 10,000; 143 over 20,000 (Nov. 2009)
- Coverage - Includes all biopharmaceuticals approved in the U.S. or European Union, plus those with filings pending or expected in the upcoming year,
those with approvals or applications denied or withdrawn in recent years, and other notable current and historical products
- Database updated quarterly - now in 8th edition/generation, >8.3 million characters, >1.2 million words
[The Sept. 2007 book 6th edition was 2 vol.,
1602 pages.]
- Indexes - In-depth, highly controlled indexing and relational links provide unprecedented access to
biopharmaceutical products and companies; ~33,000 index entries (ave. >50/product)
- Product indexes - Products/Active Agents (nomenclature), Class, Biological,
Chemical, Medical, Market Size,
Expression System/Host Cell/Source, Regulatory/Status and
Approval Date Indexes
- Company indexes -
Company, Company Role, Country, State, and Marketing Territory Indexes
- Prices:
- Individual" Web database subscriptions - $795/year.
An "individual" password may be reasonably shared among those in the same department, working on common
projects, in a small company, an information center/library, etc. (much as a book might be shared).
- Corporate subscriptions - For a somewhat higher fee, your company can have worldwide, server IP number-based, seamless desktop access to the Web database. Rates are quoted based on number of users, sites, etc. Contact the author/publisher for a quote.
- Academic/non-profit discounts - Contact the author/publisher for a rate quote.
Use of BIOPHARMA in courses and academic studies is encouraged, and may be
even be available free for class and student use.
Credit card payments are handled by Cornell University Press (CUPS).
E-Mail: biotech@biopharma.com